NCT00723112View on ClinicalTrials.gov

The Role of Erythropoietin in Myelodysplastic Syndrome

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Myelodysplastic Syndrome
Trial Locations (2)

84132

University of Utah, Salt Lake City

84148

VA Salt Lake City Health Care System, Salt Lake City

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Utah

OTHER

NCT00723112 - The Role of Erythropoietin in Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter